AAMDSIF sponsors live education events throughout the year. This includes satellite symposia at annual medical association meetings, as well as smaller live regional events where community-based health professionals can hear from leading experts. The International Bone Marrow Failure Disease Scientific Symposium is our biennial professional meeting held near Washington, DC.
Bone Marrow Failure and Myeloid Neoplasms Symposium: An Update in the Latest Advances in Diagnosis and Treatment
Saturday, March 30, 2019, 8:00am – 3:00pm
Sheraton Albuquerque Uptown, Albuquerque, NM
2019 Bone Marrow Failure and Myeloid Neoplasms Symposium: Advances in Diagnosis and Treatment
This symposium cosponsored by the University of New Mexico Comprehensive Cancer Center and the Aplastic Anemia and MDS International Foundation will provide updates on the most recent research related to the biology, diagnosis and clinical management of bone marrow failure diseases, including myelodysplastic syndromes (MDS), aplastic anemia (AA), paroxysmal nocturnal hemoglobinuria (PNH), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN).
Registration now open (livestream option also available).
Great Debates & Updates in Hematologic Malignancies
March 22-23, 2019 | Los Angeles, CA
Marina Del Rey
April 5-6, 2019 | New York, NY
Sheraton New York Times Square
Great Debates & Updates in Hematologic Malignancies, a debate-style meeting originally held exclusively in New York City, will be expanding its presence in 2019 to the Los Angeles area. This 2-day CME conference is meant for all healthcare professionals involved with or interested in the treatment of hematologic malignancies.
The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, such as multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, “not-so-benign” hematology, and so much more. For more information, visit greatdebatesinhema.com and use code “ENDORSER” for $50 off registration.
ONS 2019 Satellite Symposium Live and Enduring Program
The Many Faces of Myelodysplastic Syndromes: Managing Evolving Therapies and Counseling Patients
Wednesday, April 10, 2019, 6:00 pm - 7:30 pm
Hilton Anaheim - Pacific Ballroom A&B, Anaheim, CA
This symposium will be presented at the ONS Annual Congress in Anaheim, CA in April 2019, and is targeted to clinical nursing professionals in oncology. The program focuses on recent advances in diagnosing and treating myelodysplastic syndromes and related diseases, including AML and MDS/MPN overlap, and the role of nurses in disease management and care coordination. Case studies will be used to illustrate treatment decision-making and therapeutic challenges.
Topics will include:
- Latest developments in precision medicine in diagnosing and treating myeloid malignancies;
- Emerging treatment options for low-risk MDS, high-risk MDS, AML, and MDS/MPN overlap;
- Disease management for chronic anemia, side effects and treatment adherence;
- Psychosocial considerations and palliative care to improve the quality of life for this patient population.
Nancy Corbitt, BSN, RN, OCN, CRNI, University of Maryland Greenebaum Cancer Center, Baltimore, MD
- Tiffany Tanaka, MD, UC San Diego Moores Cancer Center, San Diego, CA
- Costandina Herbert, BSN, RN, Seattle Cancer Care Alliance, Seattle, WA
- Chris Onderdonk, LCSW, UC San Diego Hillcrest Hospital
This activity is jointly provided by Medical Learning Institute, Inc. and the Aplastic Anemia and MDS International Foundation.
Commercial Support Acknowledgement
This activity is supported by and educational grant from Celgene Corporation.
This activity was developed for nurses and nurse practitioners who are involved in the treatment or management of patients with bone marrow failure disease.
Nursing Education Purpose Statement
The purpose of this activity is to improve the knowledge and competence of nurses concerning the treatment or management of patients with bone marrow failure disease.
Registered Nurse Designation
Medical Learning Institute, Inc.
Provider approved by California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hours.
Nurse Practitioner Credit Designation
This program is pending AANP approval.